These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32123179)

  • 1. Nanobody-enabled monitoring of kappa opioid receptor states.
    Che T; English J; Krumm BE; Kim K; Pardon E; Olsen RHJ; Wang S; Zhang S; Diberto JF; Sciaky N; Carroll FI; Steyaert J; Wacker D; Roth BL
    Nat Commun; 2020 Mar; 11(1):1145. PubMed ID: 32123179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotype-selective modes of action of κ-opioid receptor agonists.
    Vardy E; Mosier PD; Frankowski KJ; Wu H; Katritch V; Westkaemper RB; Aubé J; Stevens RC; Roth BL
    J Biol Chem; 2013 Nov; 288(48):34470-83. PubMed ID: 24121503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand/kappa-opioid receptor interactions: insights from the X-ray crystal structure.
    Martinez-Mayorga K; Byler KG; Yongye AB; Giulianotti MA; Dooley CT; Houghten RA
    Eur J Med Chem; 2013 Aug; 66():114-21. PubMed ID: 23792349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
    Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ
    Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the human κ-opioid receptor in complex with JDTic.
    Wu H; Wacker D; Mileni M; Katritch V; Han GW; Vardy E; Liu W; Thompson AA; Huang XP; Carroll FI; Mascarella SW; Westkaemper RB; Mosier PD; Roth BL; Cherezov V; Stevens RC
    Nature; 2012 Mar; 485(7398):327-32. PubMed ID: 22437504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobodies as sensors of GPCR activation and signaling.
    El Daibani A; Che T
    Methods Cell Biol; 2021; 166():161-177. PubMed ID: 34752331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies.
    Staus DP; Wingler LM; Strachan RT; Rasmussen SG; Pardon E; Ahn S; Steyaert J; Kobilka BK; Lefkowitz RJ
    Mol Pharmacol; 2014 Mar; 85(3):472-81. PubMed ID: 24319111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential helical orientations among related G protein-coupled receptors provide a novel mechanism for selectivity. Studies with salvinorin A and the kappa-opioid receptor.
    Vortherms TA; Mosier PD; Westkaemper RB; Roth BL
    J Biol Chem; 2007 Feb; 282(5):3146-56. PubMed ID: 17121830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor.
    O'Connor C; White KL; Doncescu N; Didenko T; Roth BL; Czaplicki G; Stevens RC; Wüthrich K; Milon A
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11852-7. PubMed ID: 26372966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobodies to Study G Protein-Coupled Receptor Structure and Function.
    Manglik A; Kobilka BK; Steyaert J
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():19-37. PubMed ID: 27959623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway.
    Miyano K; Yoshida Y; Hirayama S; Takahashi H; Ono H; Meguro Y; Manabe S; Komatsu A; Nonaka M; Mizuguchi T; Fujii H; Higami Y; Narita M; Uezono Y
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel β-arrestin-2-biased pathway.
    Liu H; Tian Y; Ji B; Lu H; Xin Q; Jiang Y; Ding L; Zhang J; Chen J; Bai B
    Biochim Biophys Acta; 2016 Nov; 1863(11):2719-2738. PubMed ID: 27523794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for selectivity and antagonism in extracellular GPCR-nanobodies.
    Schlimgen RR; Peterson FC; Heukers R; Smit MJ; McCorvy JD; Volkman BF
    Nat Commun; 2024 May; 15(1):4611. PubMed ID: 38816420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor.
    Livingston KE; Mahoney JP; Manglik A; Sunahara RK; Traynor JR
    Elife; 2018 Jun; 7():. PubMed ID: 29932421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
    Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor.
    Che T; Majumdar S; Zaidi SA; Ondachi P; McCorvy JD; Wang S; Mosier PD; Uprety R; Vardy E; Krumm BE; Han GW; Lee MY; Pardon E; Steyaert J; Huang XP; Strachan RT; Tribo AR; Pasternak GW; Carroll FI; Stevens RC; Cherezov V; Katritch V; Wacker D; Roth BL
    Cell; 2018 Jan; 172(1-2):55-67.e15. PubMed ID: 29307491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of conformational states, dynamics, and mechanism of binding in human κ-opioid receptor complexes.
    Leonis G; Avramopoulos A; Salmas RE; Durdagi S; Yurtsever M; Papadopoulos MG
    J Chem Inf Model; 2014 Aug; 54(8):2294-308. PubMed ID: 25060329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted structures for kappa opioid G-protein coupled receptor bound to selective agonists.
    Li Q; Kim SK; Goddard WA; Chen G; Tan H
    J Chem Inf Model; 2015 Mar; 55(3):614-27. PubMed ID: 25642595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant.
    Verkhivker G
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking and free energy perturbation studies of ligand binding in the kappa opioid receptor.
    Goldfeld DA; Murphy R; Kim B; Wang L; Beuming T; Abel R; Friesner RA
    J Phys Chem B; 2015 Jan; 119(3):824-35. PubMed ID: 25395044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.